T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy
about
The embryological basis of subclinical hypertrophic cardiomyopathyResearch priorities in sarcomeric cardiomyopathiesHypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure.Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy.The systolic paradox in hypertrophic cardiomyopathy.Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy.Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.Relationship between Myocardial Extracellular Space Expansion Estimated with Post-Contrast T1 Mapping MRI and Left Ventricular Remodeling and Neurohormonal Activation in Patients with Dilated Cardiomyopathy.Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.Athletic Cardiac Adaptation in Males Is a Consequence of Elevated Myocyte Mass4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy.Integrating Genetics and Medicine: Disease-Modifying Treatment Strategies for Hypertrophic Cardiomyopathy.Myocardial tissue remodeling in adolescent obesityMyocardial T1 and T2 Mapping: Techniques and Clinical Applications.The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy.Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.Genetics and genomics of dilated cardiomyopathy and systolic heart failure.Role of cardiac MRI in diabetes.Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.Muscle dysfunction in hypertrophic cardiomyopathy: what is needed to move to translation?Myocardial T1 mapping: modalities and clinical applications.Genetic biomarkers in hypertrophic cardiomyopathy.Established and emerging cardiovascular magnetic resonance techniques for prognostication and guiding therapy in heart failure.Almanac 2014: cardiomyopathies.Individualized cardiovascular risk assessment by cardiovascular magnetic resonance.T1 mapping: non-invasive evaluation of myocardial tissue composition by cardiovascular magnetic resonance.Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.The genetic basis of hypertrophic cardiomyopathy in cats and humans.Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline.Recent Advances in Cardiovascular Magnetic Resonance: Techniques and Applications.Using genetic testing to guide therapeutic decisions in cardiomyopathy.Left ventricular outflow tract gradient is associated with reduced capillary density in hypertrophic cardiomyopathy irrespective of genotype.Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.Role of T1 Mapping in Inherited Cardiomyopathies.The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial.Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
P2860
Q27342687-2C478624-AFE3-440D-B413-2A2F41016454Q27694507-94C92CBE-F265-4612-A895-26329CC61677Q30278822-827C1A63-3C09-4B66-B8A9-6C09756F170DQ30421950-B2CE9A83-9139-4477-951A-8A3E81BA30E0Q30867239-2C7994CC-55C2-4980-AC66-3D985D0254DEQ33554999-97BD7E49-2DC8-46CB-B295-855F596A915DQ33595504-E50A9361-6F7F-4035-A73C-16817FE8129BQ33764571-36A783FB-D797-4DAE-9CF7-56D3A84B0851Q33801809-0A4BA6D9-95B5-46D2-8838-FCF0D3CEC3EEQ34543914-C9FB1617-E32F-4495-8E2A-BD6CE299B1CAQ35899352-E089F3B9-6E47-44F7-AB8E-712586FDA11DQ36026885-7E4FCDD2-E52E-46A5-BC6D-7AD5CC727FBBQ36305091-279066B1-8AAB-46A1-8FA3-197A706780AFQ36826251-6A97388D-6E29-4784-B5A1-C910A3D4E238Q36851346-9AFF1E7A-D354-41AB-8B85-0B4BCF3781B8Q36888254-AC400BCB-E412-415C-BA6B-60F9392371FCQ37310497-D903BFCE-90AB-4DB8-9AC3-037AD30DBAE7Q37589574-BF6E8196-5850-4AE6-83CF-228349AD1617Q37596065-F4F645CF-7304-4293-A5AC-7DEBD7211513Q37652430-03F7BD5B-1212-4D1F-B54B-F08B7EB37BA9Q37661546-70ABA618-ABA7-4FF8-A9D5-082158320D60Q37662894-1CAA9462-7CDA-401C-B3DC-E1A037350FB1Q37683177-273B2E1E-FD4B-44B6-9450-4502D20C8D97Q37696227-73A6ABAD-5B28-4FFE-B62E-E73A9D494D4CQ37717684-14D6AB40-1354-4CA4-9F6A-7FA078E133AEQ38125765-39E50919-0F4F-4BEC-B4E7-FECF60B393A0Q38171866-95433CB6-A487-4F04-8BD0-EB06B74160DAQ38193960-07956259-B7D7-43C0-83D2-E5302C0CB797Q38206843-E73EB4A7-6481-4D51-8A93-0BD6A7A37E32Q38270769-08ED4AC1-F597-454E-A8EC-0B8AA0815D62Q38336102-17678BDD-B24E-49AF-8938-984546A968FCQ38699748-7DEAE876-63E9-42C3-B60F-D89ADB492188Q38863215-8338D059-F06F-40EA-85A7-4544EDD0F087Q39370604-D1DB2518-4A8A-42FF-9EB6-36620F7EF5D9Q39398133-EBE34BE9-9E74-4254-9736-240CC8763ACCQ40458508-2B74F5C8-D348-4C43-8458-9E11264663B2Q41101323-E409EFD0-02E2-41CF-A782-8382920F6BDAQ41439031-4FED449E-C7AE-429D-8FCD-4C8FD9B30894Q41626761-17442E8C-545A-4F01-9EF7-C55976283835Q42278868-1C757A93-9851-4CD9-85AA-AFF34642A5B4
P2860
T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T1 measurements identify extra ...... t left ventricular hypertrophy
@en
T1 measurements identify extra ...... left ventricular hypertrophy.
@nl
type
label
T1 measurements identify extra ...... t left ventricular hypertrophy
@en
T1 measurements identify extra ...... left ventricular hypertrophy.
@nl
prefLabel
T1 measurements identify extra ...... t left ventricular hypertrophy
@en
T1 measurements identify extra ...... left ventricular hypertrophy.
@nl
P2093
P2860
P50
P1476
T1 measurements identify extra ...... t left ventricular hypertrophy
@en
P2093
Allison L Cirino
Arantxa González
Bobak Heydari
E John Orav
Javier Díez
Neal K Lakdawala
Ravi V Shah
Raymond Y Kwong
Tomas G Neilan
Yucheng Chen
P2860
P304
P356
10.1161/CIRCIMAGING.112.000333
P577
2013-04-02T00:00:00Z